Specific anxiety syndromes: current therapeutic options.
D000379:Agoraphobia / Q000523:psychology / Q000628:therapy; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000523:psychology / Q000628:therapy*; D001569:Benzodiazepines; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy; D003887:Desensitization, Psychologic; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009771:Obsessive-Compulsive Disorder / Q000628:therapy; D012559:Schizophrenia / Q000188:drug therapy; D012565:Schizophrenic Psychology
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D001569:Benzodiazepines; D007099:Imipramine